4 Publications
2022
Circadian rhythm disruption results in visual dysfunction
Mathew, Deepa⋅Luo, Qianyi and Bhatwadekar, Ashay D
FASEB BioAdvances, vol. 4, (no. 6), pp. 364-378, Jun 2022. | Journal Article
 
Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes.
Luo, Qianyi⋅Leley, Sameer P⋅Bello, Erika⋅Dhami, Hurshdeep⋅Mathew, Deepa and Bhatwadekar, Ashay Dilip
BMJ open diabetes research & care, vol. 10, (no. 3), May 2022. | Journal Article
2020
Anti-integrin therapy for retinovascular diseases.
Bhatwadekar, Ashay D⋅Kansara, Viral⋅Luo, Qianyi and Ciulla, Thomas
Expert opinion on investigational drugs, vol. 29, (no. 9), pp. 935-945, September 2020. | Journal Article
2017
Conditional Deletion of Bmal1 Accentuates Microvascular and Macrovascular Injury.
Bhatwadekar, Ashay D⋅Beli, Eleni⋅Diao, Yanpeng⋅Chen, Jonathan⋅Luo, Qianyi⋅Alex, Alpha⋅Caballero, Sergio⋅Dominguez, James M⋅Salazar, Tatiana E⋅Busik, Julia V⋅Segal, Mark S and Grant, Maria B
The American journal of pathology, vol. 187, (no. 6), pp. 1426-1435, June 2017. | Journal Article